A new class of potent non-imidazole H3 antagonists: 2-aminoethylbenzofurans
- 17 December 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (3) , 689-693
- https://doi.org/10.1016/j.bmcl.2003.11.032
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recent advances in histamine H3/H4receptor ligandsExpert Opinion on Therapeutic Patents, 2003
- Two Novel and Selective Nonimidazole H3 Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological CharacterizationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- A Comparison of Physiochemical Property Profiles of Development and Marketed Oral DrugsJournal of Medicinal Chemistry, 2003
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Histamine H3‐receptor‐mediated [35S]GTPγ[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptorsBritish Journal of Pharmacology, 2002
- Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonistsEuropean Journal of Pharmaceutical Sciences, 2001
- Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in LeukocytesJournal of Biological Chemistry, 2000
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Stereochemical aspects of the "tert-amino effect". 2. Enantio- and diastereoselectivity in the synthesis of quinolines, pyrrolo[1,2-a]quinolines, and [1,4]oxazino[4,3-a]quinolinesThe Journal of Organic Chemistry, 1989